Novo Nordisk is expanding discounted retail options for consumers who want to purchase the weight-loss medications Wegovy and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Costco, which has eight CT stores, has signed a deal with Novo Nordisk to sell Wegovy and Ozempic injections at $499 per ...

BENTONVILLE, Ark. — Sam's Club announced this week it will offer discounted prices for weight-loss drugs Ozempic and Wegovy, ...

Moderately bullish activity in Novo Nordisk (NVO), with shares up 68c, or 1.16%, near $59.70. Options volume relatively light with 42k contracts ...

Shares of Costco (NASDAQ:COST) have finally entered correction territory, dipping by close to 14% from its all-time highs.

India’s anti-obesity pharmaceutical market is valued at ₹859 crore, having recorded a five-fold increase over five years with ...

Mounjaro recorded sales of Rs 85 crore in September. Analysts say user-friendly pen formulation helped build the momentum, ...

Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore ...

Endocrinologists say the early momentum for Mounjaro was expected, given its dual indication for diabetes and obesity ...

Novo Nordisk, the company that owns both Wegovy and Ozempic, will be selling the medicine at nearly half the out-of-pocket price of other pharmacies at just $499. The company’s U.S. president David ...

Health-care companies rose as traders rotated back into a sector that had fallen out of favor. Shares of insurers such as Humana and UnitedHealth Group added to recent gains following weak performance ...